Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
Primary Industries
- Drugs
- Cancer
- Therapeutic
- Pharmaceuticals
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 6729
The Innogene License Agreement requires Innogene to purchase 100% of its supplies of Nimotuzumab for non-clinical and clinical studies and trials and 100% of its commercial supplies of Nimotuzumab from Licensor.
Patent
Technology 80.02.113
Improved Treatment Method for Cancer
80.02.113.20
US
Abandoned
627,836
1887-39
80.02.113.4
US
Issued
08/25/98
5,798,339
1887-79
80.02.113.7
US
Issued
04/08/97
5,618,846
1887-134
80.02.113.6
US
Issued
05/05/98
5,747,543
1887-133
80.02.113.8
US
Issued
01/12/99
5,859,065
1887-184
80.02.113.2
US
Abandoned
09/200,783
1887-190
80.02.113.14
80.02.171.6
US
Under
review at Patent Office
08/505,269
1887-148
80.02.171.12
US
Under
review at Patent Office
08/773,987
1887-174
80.02.171.13
Australia
Issued
02/17/94
693,780
1887-149
Patent
Technology 80.02.194
Method
of Treatment of Hormone-Unresponsive Metastatic Prostate Cancer
File
Country
Status
Ser./Pat.#
Attorney
Reference
80.02.194.1
US
Issued
07/11/95
5,432,168
1887-93
80.02.194.2
PCT
Entered
Natl. Phase
CA94/00676
1887-119
80.02.194.9
US
Issued
01/26/99
5,863,912
1887-164
IPSCIO Record ID: 233450
The Japanese Licensor grants an exclusive license to Licensors Know-How to make, have made, use, offer to sell, sell and import Compound Product throughout the world.
The Compound Product shall mean any product that was developed by Licensee or a sublicensee of Licensee for marketing as a therapeutic that contains the Compound and that is for the treatment of cancer.
IPSCIO Record ID: 236353
The Japanese Licensor grants an exclusive license to Licensors Know-How to make, have made, use, offer to sell, sell and import Compound Product throughout the world.
The Compound Product shall mean any product that was developed by Licensee or a sublicensee of Licensee for marketing as a therapeutic that contains the Compound and that is for the treatment of cancer.